Yeah I agree, LANI is going to be the difference between a $3 and $10 share price. It would be nice if BTA owned the lot as DS may be pushing to market the drug themselves (and hence probably miss the large milestone payments).
Relenza is looking fantastic at the moment. Patents got extended and GSK are actively promoting the drug. I'm looking forward to the new delivery system and increased production.
us to buy more relenza, page-5
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)